Extensively drug-resistant TB (XDR-TB) is a rare type of MDR-TB that is resistant to isoniazid and rifampin, plus any fluoroquinolone and at least one of three injectable second-line drugs (i.e. amikacin, kanamycin, or capreomycin). Because XDR-TB is resistant to the most potent TB drugs, patients are left with treatment options that are much less effective. XDR-TB is of special concern for persons with HIV infection or other conditions that can weaken the immune system. These persons are more likely to develop TB disease once they are infected, and also have a higher risk of death once they develop TB.
Browse Publications
- Downloads (91)
- NTP Service Data (10)
- Resources (3)
- Tender & Notices (71)
Follow Us On Facebook
Recent Posts
- One-day experience-sharing meeting on Active TB Case Finding using Digital Chest X-ray Technology with CAD/AI
- MD students of NMC and COSM at NTCC – 6 Dec 2024
- Farewell Program for Mr. Deepak Dahal, Undersecretary of Statistics, on His Retirement
- Nepal team participating and Presenting at The UNION world conference on lung health 2024-Bali Indonesia
- Sharing Meeting on Rapid Response Assessment of the Impact of Flooding on the National Tuberculosis Program in Nepal